Mohidin, B.; Needleman, A.; Fernando, R.; Lowe, D.M.; Wechalekar, A.; Sheaff, M.; Salama, A.; Jones, G.
Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab. J. Clin. Med. 2024, 13, 4109.
https://doi.org/10.3390/jcm13144109
AMA Style
Mohidin B, Needleman A, Fernando R, Lowe DM, Wechalekar A, Sheaff M, Salama A, Jones G.
Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab. Journal of Clinical Medicine. 2024; 13(14):4109.
https://doi.org/10.3390/jcm13144109
Chicago/Turabian Style
Mohidin, Barian, Amy Needleman, Raymond Fernando, David M. Lowe, Ashutosh Wechalekar, Michael Sheaff, Alan Salama, and Gareth Jones.
2024. "Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab" Journal of Clinical Medicine 13, no. 14: 4109.
https://doi.org/10.3390/jcm13144109
APA Style
Mohidin, B., Needleman, A., Fernando, R., Lowe, D. M., Wechalekar, A., Sheaff, M., Salama, A., & Jones, G.
(2024). Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab. Journal of Clinical Medicine, 13(14), 4109.
https://doi.org/10.3390/jcm13144109
